Scottish Health Technologies Group

A knowledge broker for Scotland's health networks     

The Scottish Health Technologies Group (SHTG) is an advisory group set up to provide assistance to NHSScotland boards when considering selected health technologies, excluding medicines which will be reviewed by the Scottish Medicines Consortium (SMC).

The remit of the SHTG is to provide advice on the evidence about the clinical and cost effectiveness of existing and new technologies likely to have significant implications for patient care in Scotland. This advice should support the planning and decision making processes in NHS boards. This includes a horizon scanning function to provide early intelligence on health technologies in development.

Share this content


Latest SHTG publications

  • What is the evidence for the clinical and cost effectiveness of single room only wards in hospitals compared with non-single room only wards?
    Evidence note

    Advice Statement
  • What is the published evidence on the accuracy, turnaround time and cost/cost effectiveness of tests to identify carbapenemase-producing Enterobacteriaceae (CPE) in hospital screening samples obtained from patients identified as at risk of CPE colonisation during clinical risk assessment?
    Evidence note
    Advcie Statement
  • What is the clinical effectiveness, safety and cost effectiveness of endovascular therapy using mechanical thrombectomy devices for patients with acute ischaemic stroke?
    Evidence note
    Advice Statement
  • What is the clinical effectiveness, cost effectiveness and safety of home health monitoring compared with usual care for patients with moderate to severe chronic obstructive pulmonary disease?
    Evidence note
    Advice Statement

SHTG meeting dates

  • 8 December 2016
  • 20 February 2017
  • 24 April 2017
  • 26 July 2017
  • 23 October 2017
  • 13 December 2017

All meetings are held in Delta House, Glasgow.